Immunotherapy for Gastric Cancer: A 2021 Update
Authors:
- Christo KoleChristo Kole
- Nikolaos CharalampakisNikolaos Charalampakis
- Sergios TsakatikasSTSergios Tsakatikas
- Nikolaos-Iasonas KourisNKNikolaos-Iasonas Kouris
- George PapaxoinisGPGeorge Papaxoinis
- Michalis V KaramouzisMichalis V Karamouzis
- Anna KoumarianouAKAnna Koumarianou
- Dimitrios SchizasDimitrios Schizas
- 17 November 2021
- journal article
- review article
- Published by Taylor & Francis in Immunotherapy
- Vol. 14 (1) , 41-64
Abstract
Gastric cancer, the fifth most frequent cancer and the fourth leading cause of cancer deaths, accounts for a devastating death rate worldwide. Since the majority of patients with gastric cancer are...Keywords
This publication has 152 references indexed in Scilit:
- Effects of cytokine-induced killer cell treatment combined with FOLFOX4 on the recurrence and survival rates for gastric cancer following surgeryExperimental and Therapeutic Medicine, 2013
- Trial watchOncoImmunology, 2012
- Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancerCancer Immunology, Immunotherapy, 2012
- Genetic Aspects of Gastric Cancer InstabilityThe Scientific World Journal, 2012
- A meta-analysis on alcohol drinking and gastric cancer riskAnnals of Oncology, 2011
- Ex-vivo expanded human NK cells express activating receptors that mediate cytotoxicity of allogeneic and autologous cancer cell lines by direct recognition and antibody directed cellular cytotoxicityJournal of Experimental & Clinical Cancer Research, 2010
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialThe Lancet, 2010
- Adoptive cell transfer: a clinical path to effective cancer immunotherapyNature Reviews Cancer, 2008
- DNA vaccines: precision tools for activating effective immunity against cancerNature Reviews Cancer, 2008
- The expression of tumor-rejection antigen “MAGE” genes in human gastric carcinomaGastroenterology, 1995